Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10072-023-06928-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chikungunya-related Guillain-Barre syndrome is most commonly demyelinating and affects multiple cranial nerves.
Neurol Res Pract
November 2024
Neurology Department, Neurology & Neurophysiology Center, Vienna, Austria.
Comment on "Distribution characteristics of antinuclear antibodies in Guillain-Barré syndrome and its relationship with disease severity".
Clin Neurol Neurosurg
October 2024
Department of Life Sciences, National Natural Science Foundation of China, Beijing, China. Electronic address:
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled Trial.
JAMA Oncol
September 2024
Duke Cancer Institute, Duke University, Durham, North Carolina.
Article Synopsis
- A study was conducted to evaluate the impact of atezolizumab before and after chemoradiation therapy (CRT) in patients with unresectable stage III non-small cell lung cancer (NSCLC), showing promise in enhancing treatment outcomes.
- The trial involved 62 patients who received four cycles of atezolizumab, followed by CRT, with the primary measure being the disease control rate at 12 weeks.
- Results indicated improved disease control and safety patterns, suggesting pre-emptive use of atezolizumab could enhance patient responses to treatment.
[Comment on the article "Guillain-Barre syndrome before and during the COVID-19 pandemic in a referral center of Mexico"].
Gac Med Mex
April 2024
Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México.
Recurrent Guillain-Barré Syndrome: Clinical Profile and Outcome - Authors' Reply.
Indian J Pediatr
October 2024
Division of Pediatric Emergency and Intensive Care Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!